TSLA Tesla Inc

Hagens Berman: Tesla Owners Hit Automaker with Class-Action Lawsuit for Nonfunctional Autopilot and Missing Standard Safety Features

Tesla owners today filed a class-action lawsuit against the automaker for knowingly selling nearly 50,000 cars with nonfunctional Enhanced Autopilot AP2.0 software that still has not met Tesla’s promises, including inoperative Standard Safety Features on affected models sold in Q4 2016 and Q1 2017, according to a lawsuit filed by Hagens Berman.

Though sold as premium automobiles with a focus on safety, the cars lack basic functions featured in cars at half the price. Further, the “Enhanced Autopilot,” for which customers paid an extra $5,000, is “essentially unusable and demonstrably dangerous,” the complaint reads.

The lawsuit, filed Apr. 19, 2017, in the U.S. District Court for the Northern District of California, states, “Unwittingly, buyers of affected vehicles have become beta testers of half-baked software that renders Tesla vehicles dangerous if engaged.”

The suit details Tesla’s deceptive rollout of both the Standard Safety Features and its new Enhanced Autopilot, which were touted as safe and “stress-free” for the driver. Consumers report Tesla vehicles equipped with the new autopilot AP2.0 “behaving as if a drunk driver is at the wheel,” according to the lawsuit, and the suit states that the automaker knew that its software was incapable of upholding its promises to purchasers.

“Tesla has endangered the lives of tens of thousands of Tesla owners across the country, and induced them to pay many thousands of dollars for a product that Tesla has not effectively designed,” said Steve Berman, managing partner of Hagens Berman, which represents the plaintiffs. “Tesla sold these vehicles as the safest sedan on the road. What consumers received were cars without standard safety enhancements featured by cars costing less than half the price of a new Tesla, and a purported ‘Enhanced Autopilot’ that operates in an erratic and dangerous manner.”

“To this day, Tesla has not released truly functional software for its Standard Safety Features or Enhanced Autopilot,” Berman added.

According to the complaint, Tesla sold about 47,000 affected Model S and Model X vehicles in Q4 2016 and Q1 2017, and damages for each model would include the value of the standard safety features that do not exist in all the affected cars, plus the $5,000 premium cost of the nonfunctional Enhanced Autopilot feature that many customers also purchased.

The lawsuit states that Tesla missed deadline after deadline that it gave purchasers. Regarding its Standard Safety Features which include automatic emergency braking, front collision warning, side collision warning and auto high beams, Tesla told consumers these features would be available by December 2016 and “roll out through over-the-air software updates,” but to date, only a dangerously defective Traffic Aware Cruise Control has actually come to fruition, according to the suit. The remaining features simply do not exist.

Tesla also promised that its Enhanced Autopilot software would be disseminated in the same timeframe; it also missed this deadline, according to the complaint.

In both instances of failed functionality and delivery, Tesla modified the text on its website, removing any previously disclosed deadlines and timeframes for functional Standard Safety Features or Autopilot. “Rather than deliver safe and advanced autopilot features, Tesla has delivered software that causes vehicles to behave erratically,” the suit states.

The lawsuit seeks to represent consumers who purchased or leased an affected Tesla, to reclaim economic losses for the premium purchasers paid for the safety features and enhanced autopilot that do not function as Tesla promised. Sign up for the lawsuit.

The lawsuit details accounts of three named plaintiffs who purchased affected Tesla vehicles for prices ranging from about $81,000 to $113,000. In each instance, when purchasers received their vehicles from Tesla, the Standard Safety Features and Enhanced Autopilot were non-functioning, despite Tesla’s website and marketing materials indicating that both features would be available in December 2016.

The suit also showcases online anecdotes from owners using Tesla’s new autopilot: “That driver also describes a situation where ‘[y]ou can be sailing along at 50 mph and the radar spots [an approaching] bridge and immediately slams on the brakes.’ ‘The other extreme is that you approach a stoplight with a car already stopped, and the Tesla doesn’t apply the brakes at all,’ said the driver. ‘It’s really a pretty scary experience,’ he said.”

“When consumers received these pricy vehicles, it became clear that Tesla’s marketing was all smoke and mirrors,” Berman said. “And Tesla knew when it made these promises that it didn’t have the capabilities to follow through on its deal. It knowingly deceived tens of thousands who put their faith in these cars and in Tesla.”

Find out more about the lawsuit against Tesla.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP is a consumer-rights class-action law firm with offices in 10 cities. More about the law firm and its successes can be found at www.hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

EN
19/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tesla Inc

Pierre FerraguÊ
  • Pierre FerraguÊ

Tesla 3Q25 Deliveries: pull-forward drives beat

Tesla reported 3Q25 production & deliveries earlier today. Please click the link below for our take on the numbers.

Anish Jog ... (+6)
  • Anish Jog
  • Daniel Ives
  • Matthew Weiss
  • Sam Brandeis
  • Scott Devitt
  • Steven Wahrhaftig
Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PEGA PEGASYSTEMS INC.
PANW PALO ALTO NETWORKS INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
IMAX IMAX CORPORATION
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
ZG ZILLOW GROUP INC. CLASS A
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
STOK STOKE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
APGE APOGEE THERAPEUTICS INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
LAC. LITHIUM AMERICAS CORP NEW
ORKA ORUKA THERAPEUTICS INC
ZBIO ZENAS BIOPHARMA INC.
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch